INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | -23.7% | 6,528 | -1.6% | 0.00% | -20.0% |
| Q2 2023 | $270 | +13.9% | 6,633 | +4.3% | 0.01% | 0.0% |
| Q1 2023 | $237 | +20.9% | 6,360 | +13.2% | 0.01% | +25.0% |
| Q4 2022 | $196 | -100.0% | 5,620 | -35.9% | 0.00% | -71.4% |
| Q3 2022 | $490,000 | +349.5% | 8,772 | +314.6% | 0.01% | +366.7% |
| Q2 2022 | $109,000 | +12.4% | 2,116 | +57.0% | 0.00% | +50.0% |
| Q1 2022 | $97,000 | -56.9% | 1,348 | -19.8% | 0.00% | -60.0% |
| Q3 2021 | $225,000 | -10.0% | 1,680 | +8.4% | 0.01% | 0.0% |
| Q2 2021 | $250,000 | +104.9% | 1,550 | +1.3% | 0.01% | +150.0% |
| Q1 2021 | $122,000 | +64.9% | 1,530 | +12.1% | 0.00% | 0.0% |
| Q4 2020 | $74,000 | +640.0% | 1,365 | +170.8% | 0.00% | – |
| Q3 2020 | $10,000 | – | 504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |